Analyzing Preclinical Data of ADCs With Stealth Body & Their Success in Making ADCs Safer

11:30 am - Thursday 11th June 2026

  • Using Fc-silent technology for ADC development
  • Explore how this approach lowers the risk of cytopenias
  • Discuss the maintenance of potent anti-cancer efficacy

Speakers:

Head of Biology
CrossPoint Therapeutics